scholarly journals Novel use of adjunctive hyperbaric therapy for fungal scleritis

2020 ◽  
Vol 48 (3) ◽  
pp. 404-406
Author(s):  
Harry Yip ◽  
Elsie Chan
Keyword(s):  
Hyperbaric Therapy

Effect of hyperbaric therapy on cerebral blood flow in a patient with fibromyalgia

2019 ◽  
Vol 178 (3) ◽  
Author(s):  
Lucia Lelli ◽  
Paolo Tanasi ◽  
Laura De Fina ◽  
Massimo Tosti Balducci ◽  
Morando Grechi
Keyword(s):  
Blood Flow ◽  
Cerebral Blood Flow ◽  
Hyperbaric Therapy

Is decompression illness possible during hyperbaric therapy? A case report

2017 ◽  
Vol 44 (3) ◽  
pp. 283-285
Author(s):  
C. Gariel ◽  
◽  
B. Delwarde ◽  
S. Beroud ◽  
R. Soldner ◽  
...  
Keyword(s):  
Case Report ◽  
Decompression Illness ◽  
Hyperbaric Therapy

Hyperbaric Therapy for Carbon Monoxide Poisoning

2005 ◽  
Vol 24 (3) ◽  
pp. 149-150 ◽  
Author(s):  
John A Henry
Keyword(s):  
Carbon Monoxide ◽  
Carbon Monoxide Poisoning ◽  
Hyperbaric Therapy

scholarly journals Livedoid vasculopathy: fast involution after anticoagulant and hyperbaric oxygen therapy

2011 ◽  
Vol 9 (2) ◽  
pp. 212-215 ◽  
Author(s):  
Patricia Weinschenker Bollmann ◽  
Andréa Kazumi Shimada ◽  
Nilceo Schwery Michalany ◽  
Ana Rita de Araújo Burgos Manhani ◽  
Auro del Giglio
Keyword(s):  
Hyperbaric Oxygen Therapy ◽  
Inflammatory Infiltrate ◽  
Oxygen Therapy ◽  
Hyperbaric Oxygenation ◽  
Systemic Disease ◽  
Rare Condition ◽  
Lower Limbs ◽  
Livedoid Vasculopathy ◽  
Hyperbaric Therapy ◽  
Fibrin Thrombi

The livedoid vasculopathy is a rare condition characterized by the presence of recurrent painful ulcers in distal extremities of lower limbs. Histologically there is thickness of dermal vessels, occlusion of its light by fibrin thrombi associated with minimal inflammatory infiltrate. It might occur as an isolated condition or be associated with an underlying systemic disease, including coagulation and collagen disorders, or neoplasms. Because it is a rare disease there is no consensus for its treatment. We report a case of a 41-year-old man with painful ulcers in the lower extremities. We did not find any associated diseases. The lesions improved dramatically after treatment with anticoagulant and hyperbaric therapy. We concluded that anticoagulation associated with hyperbaric oxygenation may be benefit for the treatment of patients with livedoid vasculopathy. However, further studies should be done with a larger population to confirm our results.

Hyperbaric Therapy

2018 ◽  
pp. 1753-1753
Author(s):  
Stephanie A. Kolakowsky-Hayner
Keyword(s):  
Hyperbaric Therapy

Hyperbaric Therapy in Hospitalized Vascular Patient

2015 ◽  
Vol 33 (2) ◽  
pp. 82
Author(s):  
Kathleen Rich
Keyword(s):  
Hyperbaric Therapy ◽  
Vascular Patient

scholarly journals Influence of hyperbaric oxygenation and its use in urinary tract diseases

2016 ◽  
Vol 56 (3) ◽  
pp. 25-32
Author(s):  
Małgorzata Skiba ◽  
Agnieszka Pedrycz
Keyword(s):  
Urinary Tract ◽  
Hyperbaric Oxygen ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Hemorrhagic Cystitis ◽  
Positive Influence ◽  
Non Invasive ◽  
Invasive Method ◽  
Hyperbaric Therapy

Abstract In this publication, we adduce examples of the use of hyperbaric oxygen therapy in urinary tract diseases. Hyperbaric oxygen therapy has been proved to have a positive influence on the kidneys of animals with diabetes, sepsis or undergoing chemotherapy. In the literature, we can also find many examples of the use of hyperbaric therapy with good clinical outcomes in human patients with prostatic hypertrophy, pyelonephritis, and hemorrhagic cystitis. The first trials of this kind of treatment of urinary tract diseases were started at the end of the twentieth century. In spite of the promising results, and numerous reports on the effectiveness of this non-invasive method of treatment, it is not currently used on a regular basis. Because many factors such as time, multiple applications, the parameters used in the hyperbaric chamber as well as the medications taken by the patient affect the quality of the result, further studies are needed to make hyperbaric therapy more suitable and safer for each patient.

Cerebral gas embolism absorption during hyperbaric therapy: theory

2001 ◽  
Vol 90 (2) ◽  
pp. 593-600 ◽  
Author(s):  
Annette B. Branger ◽  
Christian J. Lambertsen ◽  
David M. Eckmann
Keyword(s):  
Decompression Sickness ◽  
Initial Step ◽  
External Pressure ◽  
Neurological Dysfunction ◽  
Inert Gas ◽  
Gas Embolism ◽  
Royal Navy ◽  
Absorption Time ◽  
Hyperbaric Therapy

Cerebral gas embolism is a serious consequence of diving. It is associated with decompression sickness and is assumed to cause severe neurological dysfunction. A mathematical model previously developed to calculate embolism absorption time based on in vivo bubble geometry is used in which various conditions of hyperbaric therapy are considered. Effects of varying external pressure and inert gas concentrations in the breathing mixtures, according to US Navy and Royal Navy diving treatment tables, are predicted. Recompression alone is calculated to reduce absorption times of a 50-nl bubble by up to 98% over the untreated case. Lowering the inhaled inert gas concentration from 67.5% to 50% reduces absorption time by 37% at a given pressure. Bubbles formed after diving and decompression with He are calculated to absorb up to 73% faster than bubbles created after diving and decompression with air, regardless of the recompression gas breathed. This model is a useful alternative to impractical clinical trials in assessing which initial step in hyperbaric therapy is most effective in eliminating cerebral gas embolisms should they occur.

High-Altitude Decompression Sickness Treated with Hyperbaric Therapy and Extracorporeal Oxygenation

2020 ◽  
Vol 91 (2) ◽  
pp. 106-109
Author(s):  
Jacek Siewiera ◽  
Przemysław Szałański ◽  
Dariusz Tomaszewski ◽  
Jacek Kot
Keyword(s):  
Case Report ◽  
High Altitude ◽  
Decompression Sickness ◽  
Endothelial Damage ◽  
Neurological Deficits ◽  
Institute Of Medicine ◽  
First Case ◽  
Hyperbaric Therapy ◽  
Extracorporeal Oxygenation ◽  
Vv Ecmo

BACKGROUND: High-altitude decompression sickness (HADCS) is a rare condition that has been associated with aircraft accidents. To the best of our knowledge, the present paper is the first case report of a patient treated for severe HADCS using recompression therapy and veno-venous extracorporeal oxygenation (VV-ECMO) with a complete recovery.CASE REPORT: After depressurization of a cabin, the 51-yr-old jet pilot was admitted to the Military Institute of Medicine with a life-threatening HADCS approximately 6 h after landing from a high-altitude flight, in a dynamically deteriorating condition, with progressing dyspnea and edema, reporting increasing limb paresthesia, fluctuating consciousness, and right-sided paresis. Hyperbaric oxygen therapy in the intensive care mode was initiated. A therapeutic recompression with U.S. Navy Treatment Table 6 was performed with neurological improvement. Due to cardiovascular collapse, sedation, mechanical ventilation, and significant doses of catecholamines were started, followed by continuous veno-venous hemodialysis. In the face of disturbances in oxygenation, during the second day of treatment the patient was commenced on veno-venous extracorporeal oxygenation. Over the next 6 d, the patient’s condition slowly improved. On day 7, VV-ECMO was discontinued. On day 19, the patient was discharged with no neurological deficits.DISCUSSION: We observed two distinct stages during the acute phase of the disease. During the first stage, signs of hypoperfusion, neurological symptoms, and marbled skin were observed. During the second stage, multiple organ dysfunction dominated, including heart failure, pulmonary edema, acute kidney injury, and fluid overload, all of which can be attributed to extensive endothelial damage.Siewiera J, Szałański P, Tomaszewski D, Kot J. High-altitude decompression sickness treated with hyperbaric therapy and extracorporeal oxygenation. Aerosp Med Hum Perform. 2020; 91(2):106–109.

Sign in / Sign up

Export Citation Format

Share Document